Plasma calprotectin as a biomarker of mortality at antiretroviral treatment initiation in advanced HIV - pilot study.

Kamau, Faith W; Gwela, Agnes; Nyerere, Andrew K; Riitho, Victor; Njunge, James M; Ngari, Moses M; Prendergast, Andrew J; Berkley, James A

Kamau, Faith W; Gwela, Agnes; Nyerere, Andrew K; Riitho, Victor; Njunge, James M; Ngari, Moses M; Prendergast, Andrew J; Berkley, James A.

Afiliação

Kamau FW; Clinical Research, KEMRI/Wellcome Trust Research Programme, Kilifi, Kilifi County, 320-80108, Kenya.
Gwela A; Department of Molecular Biology and Biotechnology, Pan African University Institute for Basic Sciences, Technology and Innovation, Juja, Nairobi, 62000-00200, Kenya.
Nyerere AK; Clinical Research, KEMRI/Wellcome Trust Research Programme, Kilifi, Kilifi County, 320-80108, Kenya.
Riitho V; Childhood Acute Illness & Nutrition (CHAIN) Network, Nairobi, Nairobi, 43640-00100, Kenya.
Njunge JM; Department of Medical Microbiology, Jomo Kenyatta University of Agriculture and Technology, Juja, Nairobi, 62000-00200, Kenya.
Ngari MM; Blizard Institute, Queen Mary University of London, London, London, E1 2AT, UK.
Prendergast AJ; Clinical Research, KEMRI/Wellcome Trust Research Programme, Kilifi, Kilifi County, 320-80108, Kenya.
Berkley JA; Childhood Acute Illness & Nutrition (CHAIN) Network, Nairobi, Nairobi, 43640-00100, Kenya.

Wellcome Open Res ; 5: 46, 2020.

Article em En | MEDLINE | ID: mdl-33336080

Palavras-chave

Antiretroviral; Biomarker; CD4; HIV; Mortality; Adult; Neutrophil; Prognostic

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google